These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 20975525)

  • 1. Effect of low-frequency repetitive transcranial magnetic stimulation combined with physical therapy on L-dopa-induced painful off-period dystonia in Parkinson's disease.
    Kodama M; Kasahara T; Hyodo M; Aono K; Sugaya M; Koyama Y; Hanayama K; Masakado Y
    Am J Phys Med Rehabil; 2011 Feb; 90(2):150-5. PubMed ID: 20975525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. From off-period dystonia to peak-dose chorea. The clinical spectrum of varying subthalamic nucleus activity.
    Krack P; Pollak P; Limousin P; Benazzouz A; Deuschl G; Benabid AL
    Brain; 1999 Jun; 122 ( Pt 6)():1133-46. PubMed ID: 10356065
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-frequency repetitive transcranial magnetic stimulation for dyskinesia and motor performance in Parkinson's disease.
    Sayın S; Cakmur R; Yener GG; Yaka E; Uğurel B; Uzunel F
    J Clin Neurosci; 2014 Aug; 21(8):1373-6. PubMed ID: 24631324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bilateral low frequency rTMS of the primary motor cortex may not be a suitable treatment for levodopa-induced dyskinesias in late stage Parkinson's disease.
    Flamez A; Cordenier A; De Raedt S; Michiels V; Smetcoren S; Van Merhaegen-Wieleman A; Parys E; De Keyser J; Baeken C
    Parkinsonism Relat Disord; 2016 Jan; 22():54-61. PubMed ID: 26777410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repetitive transcranial magnetic stimulation for levodopa-induced dyskinesias in Parkinson's disease.
    Filipović SR; Rothwell JC; van de Warrenburg BP; Bhatia K
    Mov Disord; 2009 Jan; 24(2):246-53. PubMed ID: 18951540
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of motor performance and modulation of cortical excitability by repetitive transcranial magnetic stimulation of the motor cortex in Parkinson's disease.
    Lefaucheur JP; Drouot X; Von Raison F; Ménard-Lefaucheur I; Cesaro P; Nguyen JP
    Clin Neurophysiol; 2004 Nov; 115(11):2530-41. PubMed ID: 15465443
    [TBL] [Abstract][Full Text] [Related]  

  • 7. rTMS effects on levodopa induced dyskinesias in Parkinson's disease patients: searching for effective cortical targets.
    Koch G
    Restor Neurol Neurosci; 2010; 28(4):561-8. PubMed ID: 20714078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A network centred on the inferior frontal cortex is critically involved in levodopa-induced dyskinesias.
    Cerasa A; Koch G; Donzuso G; Mangone G; Morelli M; Brusa L; Stampanoni Bassi M; Ponzo V; Picazio S; Passamonti L; Salsone M; Augimeri A; Caltagirone C; Quattrone A
    Brain; 2015 Feb; 138(Pt 2):414-27. PubMed ID: 25414038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 1-Hz repetitive transcranial magnetic stimulation and diphasic dyskinesia in Parkinson's disease.
    Filipović SR; Bhatia KP; Rothwell JC
    Mov Disord; 2013 Feb; 28(2):245-6. PubMed ID: 23144006
    [No Abstract]   [Full Text] [Related]  

  • 10. Altered inhibitory interaction among inferior frontal and motor cortex in l-dopa-induced dyskinesias.
    Ponzo V; Picazio S; Benussi A; Di Lorenzo F; Brusa L; Caltagirone C; Koch G
    Mov Disord; 2016 May; 31(5):755-9. PubMed ID: 26861941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Motor cortex plasticity in Parkinson's disease and levodopa-induced dyskinesias.
    Morgante F; Espay AJ; Gunraj C; Lang AE; Chen R
    Brain; 2006 Apr; 129(Pt 4):1059-69. PubMed ID: 16476674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-frequency repetitive transcranial magnetic stimulation over the primary motor cortex relieves musculoskeletal pain in patients with Parkinson's disease: A randomized controlled trial.
    Li J; Mi TM; Zhu BF; Ma JH; Han C; Li Y; Yang WM; Chan P
    Parkinsonism Relat Disord; 2020 Nov; 80():113-119. PubMed ID: 32980772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-frequency transcranial stimulation of pre-supplementary motor area alleviates levodopa-induced dyskinesia in Parkinson's disease: a randomized cross-over trial.
    Lohse A; Meder D; Nielsen S; Lund AE; Herz DM; Løkkegaard A; Siebner HR
    Brain Commun; 2020; 2(2):fcaa147. PubMed ID: 33225277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-frequency repetitive transcranial magnetic stimulation over the primary foot motor area in Parkinson's disease.
    Maruo T; Hosomi K; Shimokawa T; Kishima H; Oshino S; Morris S; Kageyama Y; Yokoe M; Yoshimine T; Saitoh Y
    Brain Stimul; 2013 Nov; 6(6):884-91. PubMed ID: 23769414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of the subthalamic nucleus in impulse control disorders associated with Parkinson's disease.
    Rodriguez-Oroz MC; López-Azcárate J; Garcia-Garcia D; Alegre M; Toledo J; Valencia M; Guridi J; Artieda J; Obeso JA
    Brain; 2011 Jan; 134(Pt 1):36-49. PubMed ID: 21059746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebellar sensory processing alterations impact motor cortical plasticity in Parkinson's disease: clues from dyskinetic patients.
    Kishore A; Popa T; Balachandran A; Chandran S; Pradeep S; Backer F; Krishnan S; Meunier S
    Cereb Cortex; 2014 Aug; 24(8):2055-67. PubMed ID: 23535177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low frequency rTMS of the SMA transiently ameliorates peak-dose LID in Parkinson's disease.
    Brusa L; Versace V; Koch G; Iani C; Stanzione P; Bernardi G; Centonze D
    Clin Neurophysiol; 2006 Sep; 117(9):1917-21. PubMed ID: 16887383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AFQ056 in Parkinson patients with levodopa-induced dyskinesia: 13-week, randomized, dose-finding study.
    Stocchi F; Rascol O; Destee A; Hattori N; Hauser RA; Lang AE; Poewe W; Stacy M; Tolosa E; Gao H; Nagel J; Merschhemke M; Graf A; Kenney C; Trenkwalder C
    Mov Disord; 2013 Nov; 28(13):1838-46. PubMed ID: 23853029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-homogeneous effect of levodopa on inhibitory circuits in Parkinson's disease and dyskinesia.
    Barbin L; Leux C; Sauleau P; Meyniel C; Nguyen JM; Pereon Y; Damier P
    Parkinsonism Relat Disord; 2013 Feb; 19(2):165-70. PubMed ID: 23000298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors predictive of the development of Levodopa-induced dyskinesia and wearing-off in Parkinson's disease.
    Warren Olanow C; Kieburtz K; Rascol O; Poewe W; Schapira AH; Emre M; Nissinen H; Leinonen M; Stocchi F;
    Mov Disord; 2013 Jul; 28(8):1064-71. PubMed ID: 23630119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.